DiaMedica Therapeutics Inc. Cash And Cash Equivalents At Carrying Value

• DiaMedica Therapeutics Inc. showed an increase of +417.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from DiaMedica Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), DiaMedica Therapeutics Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,056.5%.
• Historical annual values: Fiscal year 2025: $15.65 million | Fiscal year 2024: $3.03 million | Fiscal year 2023: $4.54 million | Fiscal year 2022: $4.73 million | Fiscal year 2021: $4.71 million | Fiscal year 2020: $7.41 million | Fiscal year 2019: $3.88 million | Fiscal year 2018: $16.82 million | Fiscal year 2017: $1.35 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026